Wird geladen...
Use of Rituximab in NHL Malt Type Pregnant in I° Trimester for Two Times
Administration of rituximab, one of the basic drugs for the therapy of B-cell lymphoproliferative diseases, during pregnancy has been suspected to cause developmental fetal events, particularly if given during the first trimester of pregnancy. Therefore, use in pregnancy is not permitted. Howe ver,...
Gespeichert in:
| Veröffentlicht in: | Open Med (Wars) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
De Gruyter
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6884922/ https://ncbi.nlm.nih.gov/pubmed/31844674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/med-2019-0087 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|